L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
By R. Geiger, J. Rieckmann, Tobias Wolf, C. Basso, Yuehan Feng, Tobias Fuhrer, Maria Kogadeeva, Paola Picotti, F. Meissner, Matthias Mann and 3 more. Cell, 2016
1,537 citations recorded by the source corpus.
Summary Metabolic activity is intimately linked to T cell fate and function. Using high-resolution mass spectrometry, we generated dynamic metabolome and proteome profiles of human primary naive T cells following activation. We discovered critical changes in the arginine metabolism that led to a drop in intracellular L-arginine concentration. Elevating L-arginine levels induced global metabolic changes including a shift from glycolysis to oxidative phosphorylation in activated T cells and promoted the generation of central memory-like cells endowed with higher survival capacity and, in a mouse model, anti-tumor activity. Proteome-wide probing of structural alterations, validated by the analysis of knockout T cell clones, identified three transcriptional regulators (BAZ1B, PSIP1, and TSN) that sensed L-arginine levels and promoted T cell survival. Thus, intracellular L-arginine concentrations directly impact the metabolic fitness and survival capacity of T cells that are crucial for anti-tumor responses.
Subfields: Biotechnology, Cancer Research, Immunology
View Paper: https://www.semanticscholar.org/paper/e1fb98c2ec2dcb49cc13d61d7f670b506cd721bf
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biotechnology
In Cancer Research
- Michael D. Buck
- Joshua D. Rabinowitz
- R. Sowell
- Erika L. Pearce
- S. Kaech
- Alec C. Kimmelman
- C. Lyssiotis
- M. Haigis
In Immunology
Citations in the corpus
- The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses (2020, background): “For example, L-Arg is required for the expression of the CD3ζ chain and therefore crucial for TCR signaling and cytotoxicity (217, 218).”
- Metabolic Instruction of Immunity (2017, positive): “Several recent studies have highlighted the critical roles of other amino acids such as arginine, serine, and glycine in driving T cell expansion and antitumor activity, but how the availability of these fluctuate within the tumor microenvironment is not clear (Geiger et al., 2016; Ma et al., 2017).”
- Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy. (2020, background): “CD8+ T cells especially benefit from L-arginine uptake by enhanced survival, memory formation and anti-tumor efficacy (Geiger et al., 2016).”
- Metabolic Interactions in the Tumor Microenvironment (2017, background): “enhances the bioenergetic profile of T cells, leading to a central memory like T cell state and improved anti-tumor activity [88].”
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy (2019, background): “For example, arginine has important roles in T cell function 181 , and competition with cancer cells and other cells of the TME for this amino acid might result in suppression of the antitumour activity of T cells.”
- The Principles of Engineering Immune Cells to Treat Cancer (2017, background): “Recent studies indicate that L-arginine has an important role in regulating T cell metabolism, as supplementation of the culture medium with L-arginine resulted in decreased protein expression of glycolytic enzymes, while Krebs cycle and serine biosynthetic pathway enzyme expression was increased (G”
- Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity (2020, background): “We observed metabolic signatures enriched with CD that have been correlated with T cell activation, including sugar and amino acid metabolism (Figure 3K; Geiger et al., 2016; MacIver et al., 2013; Sinclair et al., 2013;Wei et al., 2017).”
- Understanding the intersections between metabolism and cancer biology (2017, neutral): “High arginine levels promote enhanced T cell survival and anti-tumor activity (Geiger et al., 2016), and therapies that Cell.”